[1] Tsai HC,Baylin SB. Cancer epigenetics:linking basic biology to clinical medicine[J]. Cell Res,2011,21 (3):502-517. [2] Hundt S,Haug U,Brenner H. Blood markers for early detection of colorectal cancer:a systematic review[J]. Cancer Epidemiol Biomarkers Prev,2007,16 (10):1935-1953. [3] Kulasingam V,Diamandis EP. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies [J]. Nat Clin Pract Oncol,2008,5(10):588-599. [4] Glinka A,Wu W,Delius H,et al. Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction[J]. Nature,1998,391(6665):357-362. [5] Peifer M,Polakis P. Wnt signaling in oncogenesis and embryogenesis-a look outside the nucleus[J]. Science, 2000,287(5458):1606-1609. [6] Yang Y. Wnts and wing:Wnt signaling in vertebrate limb development and musculoskeletal morphogenesis[J]. Birth Defects Res C Embryo Today,2003,69(4):305-317. [7] Sem?nov MV,Tamai K,Brott BK,et al. Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6[J]. Curr Biol,2001,11(12):951-961. [8] Mao B,Wu W,Davidson G,et al. Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling[J]. Nature,2002,417(6889):664-667. [9] Menezes ME,Devine DJ,Shevde LA,et al. Dickkopf1:a tumor suppressor or metastasis promoter?[J]. Int J Cancer, 2012,130(7):1477-1483. [10] Forget MA,Turcotte S,Beauseigle D,et al. The Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types[J]. Br J Cancer,2007,96(4):646-653. [11] Hirata H,Hinoda Y,Nakajima K,et al. Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma[J]. Int J Cancer, 2011,128(8):1793-1803. [12] Mitra A,Menezes ME,Shevde LA,et al. DNAJB6 induces degradation of beta-catenin and causes partial reversal of mesenchymal phenotype[J]. J Biol Chem,2010, 285(32): 24686-24694. [13] El-Serag HB,Marrero JA,Rudolph L,et al. Diagnosis and treatment of hepatocellular carcinoma[J]. Gastroenterology, 2008,134(6):1752-1763. [14] Sato N,Yamabuki T,Takano A,et al. Wnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapy[J]. Cancer Res, 2010,70(13):5326-5336. [15] Tung EK,Mak CK,Fatima S,et al. Clinicopathological and prognostic significance of serum and tissue Dickkopf-1 levels in human hepatocellular carcinoma[J]. Liver Int,2011,31(10): 1494-1504. [16] Shen Q,Fan J,Yang XR,et al. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma:a large-scale,multicentre study[J]. Lancet Oncol,2012, 13(8):817-826. [17] Yamabuki T,Takano A,Hayama S,et al. Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas[J]. Cancer Res,2007,67(6):2517-2525. [18] Sheng SL,Huang G,Yu B,et al. Clinical significance and prognostic value of serum Dickkopf-1 concentrations in patients with lung cancer[J]. Clin Chem,2009,55(9):1656-1664. [19] Lee HS,Lee HE,Park do J,et al. Clinical significance of serum and tissue Dickkopf-1 levels in patients with gastric cancer[J]. Clin Chim Acta,2012,413(21/22):1753-1760. [20] Gomceli I,Bostanci EB,Ozer I,et al. A novel screening biomarker in gastric cancer:serum Dickkopf-1[J]. Hepato-gastroenterology, 2012,59(117):1661-1664. [21] Voorzanger-Rousselot N,Goehrig D,Journe F,et al. Increased Dickkopf-1 expression in breast cancer bone metastases [J]. Br J Cancer, 2007,97(7):964-970. [22] Voorzanger-Rousselot N,Journe F,Doriath V,et al. Assessment of circulating Dickkopf-1 with a new two-site immunoassay in healthy subjects and women with breast cancer and bone metastases[J]. Calcif Tissue Int, 2009,84(5):348-354. [23] Feldmann R,Schierl M,Fink AM,et al. Serum levels of glycoprotein Dickkopf-1 in patients with cutaneous malignant melanoma:a prospective pilot study[J]. Dermatology, 2011, 222(2):171-175. [24] Kaiser M,Mieth M,Liebisch P,et al. Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myeloma[J]. Eur J Haematol, 2008, 80(6): 490-494. [25] Politou MC,Heath DJ,Rahemtulla A,et al. Serum concentrations of Dickkopf-1 protein are increased in patients with multiple myeloma and reduced after autologous stem cell transplantation [J]. Int J Cancer, 2006,119(7):1728-1731. [26] Jiang T,Wang S,Huang L,et al. Clinical significance of serum DKK-1 in patients with gynecological cancer[J]. Int J Gynecol Cancer, 2009,19(7):1177-1181. [27] Lee N,Smolarz AJ,Olson S,et al. A potential role for Dkk-1 in the pathogenesis of osteosarcoma predicts novel diagnostic and treatment strategies[J]. Br J Cancer, 2007,97(11):1552-1559. [28] Roato I,D'Amelio P,Gorassini E,et al. Osteoclasts are active in bone forming metastases of prostate cancer patients[J]. PLoS One, 2008,3(11):3627. [29] 郭长城,罗 俊,杨丰强,等. 膀胱癌患者血清DKK-1和DKK-3 表达及其临床意义[J]. 肿瘤,2013,33(1):81-84. |